P

Pacira BioSciences
D

PCRX

17.430
USD
-0.10
(-0.57%)
Market Closed
Volume
0
EPS
3
Div Yield
-
P/E
-9
Market Cap
804,799,573
Related Instruments
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    AMRN
    -0.01500
    (-2.88%)
    0.50510 USD
    B
    BHC
    -0.27000
    (-3.08%)
    8.48500 USD
    H
    HZNP
    0
    (0%)
    0.000000 USD
    M
    MNK
    -0.06490
    (-16.07%)
    0.33900 USD
    R
    RDNT
    -1.520
    (-1.87%)
    79.570 USD
    T
    TEVA
    -0.315
    (-1.88%)
    16.440 USD
    More
News

Title: Pacira BioSciences

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.